Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Clinical trial NCT01149850 · COMPLETED
Trial details
- NCT number
- NCT01149850
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-28
- Primary completion
- 2023-12-08
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.